Article Details

On March, 20 BioSyent Inc. (RX) EPS Estimated At $0.11

Retrieved on: 2019-03-03 00:15:33

Tags for this article:

Click the tags to see associated articles and topics

On March, 20 BioSyent Inc. (RX) EPS Estimated At $0.11. View article details on HISWAI:

Excerpt

<div>Wall Street now forecasts 22.22 % EPS growth despite BioSyent Inc. ... Inc (TSE:ACB) CCO Cam Battley on Spin-out and <b>Canopy Growth Corp</b> ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up